|
ACRS
|
Aclaris Therapeutics, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
RGNX
|
REGENXBIO Inc.
|
0.09%
|
US
|
NASDAQ
|
|
PLRX
|
Pliant Therapeutics, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
INVA
|
Innoviva, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
INBX
|
Inhibrx, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
IMGN
|
ImmunoGen, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
GRFS
|
Grifols, S.A.
|
0.09%
|
US
|
NASDAQ
|
|
GERN
|
Geron Corporation
|
0.09%
|
US
|
NASDAQ
|
|
CRNX
|
Crinetics Pharmaceuticals, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
COLL
|
Collegium Pharmaceutical, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
BLU
|
BELLUS Health Inc.
|
0.09%
|
CA
|
TSX
|
|
NVAX
|
Novavax, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
KURA
|
Kura Oncology, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
ALLO
|
Allogene Therapeutics, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
TBPH
|
Theravance Biopharma, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
RAPT
|
RAPT Therapeutics, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
PRVB
|
Provention Bio, Inc.
|
0.07%
|
US
|
NASDAQ
|